|
Mr. Schroeder, founder of CTI, previously held numerous faculty positions at the University of Cincinnati, College of Medicine. Most recently, Mr. Schroeder was Associate Professor of Pathology and Laboratory Medicine and Internal Medicine. Mr. Schroeder was also Director of the Transplantation Division in the Department of Pathology and Laboratory Medicine at the University Hospital. Mr. Schroeder was also the founding Executive Vice President of Clinical Development at SangStat Medical Corporation where he oversaw the development of biological agents, generic drugs, diagnostics, preservation solutions and therapeutic agents for use in the transplant field. During his almost 25 years of clin drugs, diagnostics, preservation solutions and therapeutic agents for use in the transplant field. During his almost 25 years of clinical, academic and industry experience, Mr. Schroeder has authored or co-authored more than 200 book chapters and peer reviewed articles in the areas of Immunology, Pharmacology and Immunosuppression. He has presented more than 300 papers at national and international conferences and was visiting faculty lecturer on approximately 175 occasions at national and international medical centers, hospitals and conferences. He is the recipient of more than 30 awards and grants from various institutions. Mr. Schroeder has served as a reviewer to numerous FDA Advisory Panels, including CDER and CBER. Mr. Schroeder has US and global experience in leading phase I - IV drug development programs and consults with pharmaceutical companies on strategic decisions surrounding clinical and commercial drug development issues. | 